Rigel Pharmaceuticals CEO Raul Rodriguez's 2020 pay rises 16% to $3M
Rigel Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 6, 2021
Rigel Pharmaceuticals reported fiscal year 2020 executive compensation information on April 6, 2021.
In 2020, five executives at Rigel Pharmaceuticals received on average a compensation package of $1.5M, a 15% increase compared to previous year.
Average pay of disclosed executives at Rigel Pharmaceuticals
Raul R. Rodriguez, Chief Executive Officer, received $3M in total, which increased by 16% compared to 2019. 67% of Rodriguez's compensation, or $2M, was in option awards. Rodriguez also received $298K in non-equity incentive plan, $662K in salary, as well as $11K in other compensation.
Dean L. Schorno, Chief Financial Officer, received a compensation package of $1.2M, which increased by 16% compared to previous year. 51% of the compensation package, or $613K, was in option awards.
Dolly A. Vance, Executive Vice President, Corporate Affairs, General, earned $1.2M in 2020, a 1% increase compared to previous year.
David A. Santos, Executive Vice President and Chief Commercial Officer, received $1.2M in 2020.
Wolfgang Dummer, Chief Medical Officer, earned $730K in 2020, a 6% decrease compared to previous year.
Related executives
Raul Rodriguez
Rigel Pharmaceuticals
Chief Executive Officer
Dean Schorno
Rigel Pharmaceuticals
Chief Financial Officer
Dolly Vance
Rigel Pharmaceuticals
Executive Vice President, Corporate Affairs, General
Wolfgang Dummer
Rigel Pharmaceuticals
Chief Medical Officer
David Santos
Rigel Pharmaceuticals
Executive Vice President and Chief Commercial Officer
You may also like
Source: SEC filing on April 6, 2021.